510(k) PRE-SUBMISSION REVIEW

Find gaps in your 510(k)
before FDA review

For medical device companies preparing a 510(k), reviewing documentation, or validating their FDA submission strategy before review.

Best for companies with a developed device, documentation in progress, or a defined US market entry plan.

Trusted by regulated market teams

Not fully confident your 510(k) is ready for FDA review?

Before you submit, make sure your documentation, predicate strategy, and substantial equivalence rationale are aligned with FDA expectations.

If route, predicate, claims, evidence or eSTAR structure are still uncertain, Sobel can help identify what to fix, confirm or organize next.

Women's hands pointing to information in documents in a business setting.

A complete-looking 510(k) can still have weak logic

Your documentation may look organized, but FDA review depends on the reasoning behind the submission: route choice, predicate comparison, intended use, technological differences, claims and evidence.

Common issues before submission

attention icon

What can trigger FDA questions

THE SOLUTION

Clarify your 510(k) strategy before you move forward

Sobel helps medical device companies review their regulatory path, documentation logic, and submission risks before FDA review.

Anvisa registration Sobel

What you receive

Your deliverables are designed to make the 510(k) logic easier to review, organize and defend internally.

One - Navy Blue

Predicate & Route Memo

Clarify the path before building the file.

Predicate & Claims Check

Make sure your comparison supports your claims.

Two - Navy Blue

Evidence Gap Review

See whether your data supports the submission.

Three - Navy Blue

Submission Package Readiness

Prepare the file for a smoother review.

Four - Navy Blue

Simple and structured 510(k) preparation

A clear workflow helps your team reduce uncertainty before the submission is assembled.

1

You send your device information

Share available documentation, labeling, intended use, claims, and product details.

2

We review your regulatory position

We assess your 510(k) pathway, predicate logic, and submission risks.

3

We identify the main gaps

We highlight documentation, testing, labeling, or SE issues that may create questions.

4

We organize the next steps

You receive a clear view of what should be corrected or completed before moving forward.

5

You move forward with more clarity

Use the review to prepare your submission path with fewer surprises.

Why companies choose Sobel for 510(k) support

Specialized regulatory support for companies preparing documentation, FDA strategy, and US market entry.

Regulatory review before costly rework

We help identify gaps before they become delays, questions, or resubmission issues.

Support for foreign manufacturers

We help companies understand FDA expectations when entering the US market.

510(k), documentation, and compliance experience

Our support connects regulatory strategy with technical documentation and market access.

Clear next steps for your team

You receive practical direction on what to correct, complete, or review before moving forward.

FDA package 510k

Tell Us About Your 510(k) Readiness

Share where you are in the process, and we’ll identify how Sobel can support your next regulatory step.

Frequently asked questions

Sobel can help review your device information, intended use, claims, and available evidence to assess whether your predicate logic is strong enough or needs further clarification before submission.

We review your device positioning, intended use, technology, risk profile, and regulatory context to help clarify whether your current 510(k) path appears aligned with FDA expectations.

Yes. If your team has already started preparing documentation, Sobel can review the current materials, identify gaps, and help clarify what may need to be corrected, completed, or strengthened before moving forward.

Ideally, your company should have a defined medical device, intended use, target market, and at least some technical, labeling, testing, or regulatory documentation available for review.

Newsletter

Subscribe to our newsletter to receive the latest updates and insights.

You may unsubscribe at any time using the link in our newsletter.